Sorina Gorcenco
11 – 17 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2022
-
Mark
Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3
- Contribution to journal › Article
- 2020
-
Mark
New generation genetic testing entering the clinic
- Contribution to journal › Article
-
Mark
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3
- Contribution to journal › Article
-
Mark
Ataxia project in Scania, Sweden: Study outline and current status
- Contribution to journal › Published meeting abstract
- 2019
-
Mark
Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
- Contribution to journal › Letter
- 2017
-
Mark
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS and neurological symptoms
- Contribution to journal › Article
-
Mark
Ataxia-pancytopenia syndrome with SAMD9L mutations
- Contribution to journal › Article
- « previous
- 1
- 2
- next »
